Article

Neurotrophin and Adipokine Signatures Associated with Visceral Adiposity–Driven Cardiometabolic and Endocrine Risk in Polycystic Ovary Syndrome

2026-01-30

Abstract excerpt

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine–metabolic disorder as-sociated with insulin resistance (IR), visceral adiposity, and increased cardiometabolic risk. The visceral adiposity index (VAI) is a validated surrogate marker of adipose tissue dysfunction, but its relationship with circulating neurotrophins and adipokine balance in PCOS remains incompletely understood. In this study, 100 women...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4a2ab520-faad-5683-ab09-0e2a9408ae6a
DOI: 10.20944/preprints202601.2399.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Neurotrophin and Adipokine Signatures Associated with Visceral Adiposity–Driven Cardiometabolic and Endocrine Risk in Polycystic Ovary SyndromeDOI 10.20944/preprints202601.2399.v1Read

The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk.Semantic proximity Read

Visceral Adiposity Index in Relation to Rotterdam Phenotypes of Polycystic Ovary SyndromeSemantic proximity Read

Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.Semantic proximity Read

Adipokine, endocrine, and fibrinolysis-related alterations across abdominal obesity and metabolic syndrome phenotypes in young adults.Semantic proximity Read

Metabolic risk in PCOS: phenotype and adiposity impact.Semantic proximity Read

Visceral Adiposity Index (VAI) Levels in Patients with Different Phenotypes of Polycystic Ovary Syndrome (PCOS)Semantic proximity Read

Divergent pathophysiological drivers of polycystic ovary syndrome: insulin resistance independently fuels the hyperandrogenic phenotype whilst neuroendocrine factors dominate non-hyperandrogenic presentations.Semantic proximity Read

Pathophysiology of human visceral obesity: an update.Semantic proximity Read

Systematic variant-to-gene mapping highlights <i>TGFB2</i> and <i>VEGFA</i> as adipokine-coding genes with non-obese, insulin-resistance-like characteristics and distinct disease risksSemantic proximity Read

Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.Semantic proximity Read

Cardiovascular Biomarkers of Obesity and Overlap With Cardiometabolic Dysfunction.Semantic proximity Read

The Accumulation of Visceral Fat in Postmenopausal Women: The Combined Impact of Prenatal Genetics, Epigenetics, and Fat Depot Heterogeneity—A Descriptive ReviewSemantic proximity Read